An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.4, 2000-04, pp. : 829-840

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rufinamide: a new anti-epileptic medication

By Hakimian Shahin Cheng-Hakimian Andrea Anderson Gail D Miller John W

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1931-1940

Informa Healthcare

Access to resources Recommend Favorite

Recent trends in the development of new anti-epileptic drugs

By Wolfe J.F. Greenwood T.D. Mulheron J.M.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 361-381

Informa Healthcare

Access to resources Recommend Favorite

New anti-epileptic drugs

By Walker M.C. Sander J.W.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1497-1510

Informa Healthcare

Access to resources Recommend Favorite

Anti-epileptic drugs in pregnancy: current safety and other issues

By Morrow James I Craig John J

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 445-456

Informa Healthcare

Access to resources Recommend Favorite

The new generation of anti-epileptic drugs

By Patsalos P.N.

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 87-106

Informa Healthcare

Access to resources Recommend Favorite